Searchable abstracts of presentations at key conferences in endocrinology

ea0099p523 | Pituitary and Neuroendocrinology | ECE2024

Characterization of patients stopping GH therapy for childhood-onset growth hormone deficiency in belgium - luxemburg

Laure Boutsen , Muriel Thomas , Willem Staels , Philippe Lysy , Marianne Becker , Rochtus Anne , Emese Boros , De Waele Kathleen , Dotrement Hilde , Anne-Simone Parent , Klink Daniel , Olimpia Chivu , Guy Massa , Dominique Beckers , Depoorter sylvia , Nele Reynaert , Karl Logghe , De Schepper Jean

Background: Growth hormone deficiency (GHD) in children comes in different etiologies and can be either isolated or combined with other pituitary hormone deficiencies. The diversity in GHD types and the variable duration of GH therapy complicate assessments of long-term treatment outcome. We characterized GHD patients at the end of GH therapy in Belgium and Luxemburg and evaluated height and adiposity outcomes in relation to GHD type.Methods: Anthropomet...

ea0037oc12.5 | Pituitary – Clinical | ECE2015

The clinical characteristics of X-linked acro-gigantism syndrome

Daly Adrian , Trivellin Giampaolo , Rostomyan Liliya , Yuan Bo , Choong Catherine , Young Jacques , Mantovani Giovanna , Naves Luciana , Lysy Philippe , Cheetham Tim , Shah Nalini , Metzger Daniel , Zatelli Maria Chiara , Strebkova Natalia , Mazerkina Nadia , Collins Michael , Lodish Maya Beth , Lupski James , Stratakis Constantine , Beckers Albert

X-linked acro-gigantism (X-LAG) is a rare novel genomic syndrome of pituitary gigantism that has a typical onset within the first year of life in children of normal or even low birth weight. X-LAG patients have a microduplications on chromosome Xq26.3 that includes a gene GPR101, which is highly upregulated in pituitary tumor tissue of affected patients. We performed a study of all 18 known X-LAG syndrome patients currently in the NICHD-University of Liège databa...